In-hospital medication reviews reduce unidentified drug-related problems

European Journal of Clinical Pharmacology

Volumn 69, Issue 3, 2013, Pages 647-655

  Bondesson, Åsa ^a,b   Eriksson, Tommy ^b   Kragh, Annika ^b   Holmdahl, Lydia ^c   Midlöv, Patrik ^d   Höglund, Peter ^b  

^a Region Skåne ^*  (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d LUND UNIVERSITY   (Sweden)

Author keywords

Clinical pharmacist; Drug related problem; In patient; Medication review; Multiprofessional team

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; THEOPHYLLINE; WARFARIN;

AGED; ARTICLE; CONTROLLED STUDY; COUGHING; CREATININE CLEARANCE; DRUG INDUCED DISEASE; DRUG MONITORING; ELDERLY CARE; FATIGUE; FEMALE; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HEALTH IMPACT ASSESSMENT; HOSPITAL CARE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; PATIENT SATISFACTION; PHARMACIST; PHARMACOEPIDEMIOLOGY; POLYPHARMACY; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; SIMULATION; SWEDEN; XEROSTOMIA;

AGE FACTORS; AGED; AGED, 80 AND OVER; ATTITUDE OF HEALTH PERSONNEL; COOPERATIVE BEHAVIOR; DRUG THERAPY; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HOSPITALS, UNIVERSITY; HUMANS; INTERDISCIPLINARY COMMUNICATION; LENGTH OF STAY; MALE; MEDICATION ADHERENCE; MEDICATION RECONCILIATION; PATIENT CARE TEAM; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; POLYPHARMACY; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 84877130482     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-012-1368-5     Document Type: Article

References (38)

1. Strand LM, Morley PC, Cipolle RJ et al (1990) Drug-related problems: their structure and function. DICP 24(11):1093-1097
2. Einarson TR (1993) Drug-related hospital admissions. Ann Pharmacother 27(7-8):832-840
3. Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: a meta- analysis of prospective studies. JAMA 279(15):1200-1205
4. Beijer HJ, de Blaey CJ (2002) Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 24(2):46-54
5. Col N, Fanale JE, Kronholm P (1990) The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 150(4):841-845
6. Bero LA, Lipton HL, Bird JA (1991) Characterization of geriatric drug-related hospital readmissions. Med Care 29(10):989-1003
7. Azaz-Livshits T, Levy M, Sadan B et al (1998) Computerized survelliance of adverse drug reactions in hospital: pilot study. Br J Clin Pharmacol 45(3):309-314
8. Bates DW, Spell N, Cullen DJ et al (1997) The costs of adverse drug events in hospitalized patients. Adverse drug events prevention study group. JAMA 277(4):307-311
9. Classen DC, Pestotnik SL, Evans RS et al (1997) Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 277(4):301-306
10. Winterstein AG, Sauer BC, Hepler CD et al (2002) Preventable drug-related hospital admissions. Ann Pharmacother 36(7-8):1238-1248
11. European Society of Clinical Pharmacy What is clinical pharmacy? In: wwwescpweborg/site/cms/contentViewArticleasp?article = 1712ed.
12. Lipton HL, Bero LA, Bird JA et al (1992) The impact of clinical pharmacists' consultations on physicians' geriatric drug prescribing. A randomized controlled trial. Med Care 30(7):646-658
13. Bjornson DC, Hiner WO Jr, Potyk RP et al (1993) Effect of pharmacists on health care outcomes in hospitalized patients. Am J Hosp Pharm 50(9):1875-1884
14. Rich MW, Beckham V, Wittenberg C et al (1995) A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 333(18):1190-1195
15. Scullin C, Scott MG, Hogg A et al (2007) An innovative approach to integrated medicines management. J Eval Clin Pract 13(5):781-788
16. Boyko WL Jr, Yurkowski PJ, Ivey MF et al (1997) Pharmacist influence on economic and morbidity outcomes in a tertiary care teaching hospital. Am J Health Syst Pharm 54(14):1591-1595
17. McMullin ST, Hennenfent JA, Ritchie DJ et al (1999) A prospective, randomized trial to assess the cost impact of pharmacist- initiated interventions. Arch Intern Med 159(19):2306-2309
18. Lannigan NA (1994) Screening for pharmaceutical care issues on a general surgical unit. Pharm J 252:134-135
19. Gillespie U, Alassaad A, Henrohn D et al (2009) A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older a randomized controlled trial. Arch Intern Med 169(9):894-900
20. The National Board of Health and Welfare (2003) [Indikatorer för utvärdering av kvaliteten i äldres läkemedelsterapi- Socialstyrelsens förslag]. Stockholm
21. Cipolle RJ, Strand LM, Morley PC (1998) Pharmaceutical care parctice. The McGraw-Hill Companies Inc, New York
22. Hatoum HT, Hutchinson RA, Witte KW et al (1988) Evaluation of the contribution of clinical pharmacists: inpatient care and cost reduction. Drug Intell Clin Pharm 22(3):252-259
23. Blix HS, Viktil KK, Reikvam A et al (2004) The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals. Eur J Clin Pharmacol 60(9):651-658
24. Blix HS, Viktil KK, Moger TA et al (2006) Characteristics of drug-related problems discussed by hospital pharmacists in multidisciplinary teams. Pharm World Sci 28(3):152-158
25. Mannheimer B, Ulfvarson J, Eklof S et al (2006) Drug-related problems and pharmacotherapeutic advisory intervention at a medicine clinic. Eur J Clin Pharmacol 62(12):1075-1081
26. Barber ND, Batty R, Ridout DA (1997) Predicting the rate of physician-accepted interventions by hospital pharmacists in the United Kingdom. Am J Health Syst Pharm 54(4):397-405
27. Lee J, McPherson ML (2006) Outcomes of recommendations by hospice pharmacists. Am J Health Syst Pharm 63(22):2235-2239
28. Bosma L, Jansman FG, Franken AM et al (2008) Evaluation of pharmacist clinical interventions in a Dutch hospital setting. Pharm World Sci 30(1):31-38
29. van Mil JW, Westerlund LO, Hersberger KE et al (2004) Drug-related problem classification systems. Ann Pharmacother 38(5):859-867
30. Donabedian A (2003) An introduction to quality assurance in health care. Oxford University Press, Inc., New York
31. Wilson S, Ruscoe W, Chapman M et al (2001) General practitioner-hospital communications: a review of discharge summaries. J Qual Clin Pract 21(4):104-108
32. Gleason KM, Groszek JM, Sullivan C et al (2004) Reconciliation of discrepancies in medication histories and admission orders of newly hospitalized patients. Am J Health Syst Pharm 61(16):1689-1695
33. Midlov P, Bergkvist A, Bondesson A et al (2005) Medication errors when transferring elderly patients between primary health care and hospital care. Pharm World Sci 27(2):116-120
34. Bondesson A, Hellstrom L, Eriksson T et al (2009) A structured questionnaire to assess patient compliance and beliefs about medicines taking into account the ordered categorical structure of data. J Eval Clin Pract 15(4):713-723. doi: 10.1111/j.1365-2753.2008.01088.x
35. Midlov P, Holmdahl L, Eriksson T et al (2008) Medication report reduces number of medication errors when elderly patients are discharged from hospital. Pharm World Sci 30(1):92-98
36. Midlov P, Deierborg E, Holmdahl L et al (2008) Clinical outcomes from the use of medication report when elderly patients are discharged from hospital. Pharm World Sci 30(6):840-845. doi: 10.1007/s11096-008-9236-1
37. Bergkvist A, Midlov P, Hoglund P et al (2009) Improved quality in the hospital discharge summary reduces medication errors-LIMM: Landskrona Integrated Medicines Management. Eur J Clin Pharmacol 65(10):1037-1046. doi: 10.1007/s00228-009-0680-1
38. Bergkvist A, Midlov P, Hoglund P et al (2009) A multi-intervention approach on drug therapy can lead to a more appropriate drug use in the elderly. LIMM-Landskrona Integrated Medicines Management. J Eval Clin Pract 15(4):660-667. doi: 10.1111/j.1365-2753.2008.01080.x